Novus Acquisition & Development Corp. announced earnings results for the first quarter ended March 31, 2017. Revenue increased by 43% to $27,224 for the three months ended March 31, 2017, as compared to the first quarter of 2016. This increase was primarily due to increased awareness and visibility of the Novus MedPlan offering and the improvement in key performance indicators (KPI) in the company's in-house marketing efforts. Operating and net income increased by 48% to $9,834 for the three months ended March 31, 2017, as compared to the first quarter of 2016.